Article info
PDFHeart failure and cardiomyopathies
Original article
Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes
- Correspondence to Dr Stanko Skrtic, AstraZeneca R&D Gothenburg, Mölndal SE-431 83, Sweden; stanko.skrtic{at}astrazeneca.com
Citation
Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes
Publication history
- Received April 16, 2016
- Revised August 18, 2016
- Accepted August 21, 2016
- First published September 19, 2016.
Online issue publication
February 16, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/